AnPac Bio-Medical Science Co Accounts Payable

As of the most recent data (April 2023), ANPC shows a accounts payable of $0. That compares with $3.7M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANPC's accounts payable is now $0 (was $3.7M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AnPac Bio-Medical Science Co is outperforming or lagging.

Tracking ANPC's accounts payable over time shows whether AnPac Bio-Medical Science Co is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $3.7M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has AnPac Bio-Medical Science Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.

AnPac Bio-Medical Science Co's accounts payable is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.